ACIU: Pendapatan lan volume dodolan AC Immune SA
The high risks associated with AC Immune (ACIU) are driven by the outcomes of final clinical trials for Alzheimer's disease treatments. The company's sales financial results help track revenue dynamics, where 0.03 indicates the current level. R&D centers are based in Switzerland, while product manufacturing is delegated to external contractors. Cash flow stability is absent, as capitalization relies on grants and the success of future regulatory approvals.
Rincian metrik komprehensif lan analitis AC Immune SA (ACIU)
- nilai saham lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal AC Immune|ACIU - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas AC Immune S.A.|ACIU - Gunggung utang perusahaan|Utang-utang marang aset resik AC Immune SA|ACIU - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan AC Immune|Rasio likuiditas darurat acimmune.com
- rincian asil keuangan lan kelipatan valuasi:
ACIU - Bathi resik|Bathi resik sing dikarepake AC Immune|ACIU - Koefisien rega marang bathi|Pangali Forward P/E acimmune.com|ACIU - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan AC Immune SA|ACIU - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan AC Immune|ACIU - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan acimmune.com|ACIU - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep AC Immune
- statistik dodolan lan pendapatan perusahaan:
Ringkesan analisis perusahaan:AC Immune
Daily revenue captures the business's operational activity in real time, allowing for an assessment of cash flow resilience against inflationary shocks. For AC Immune (ACIU), this metric reflects the effectiveness of licensing agreements with pharma behemoths. By analyzing the company's product realization chart, an investor can see the dynamics of funding inflows for clinical developments. The stability of the line confirms the reliability of partnership alliances, while sharp fluctuations may signal a revision of project financing terms.
Perusahaan pesaing
Dodolan perusahaan Biogen Idec (BIIB)|Dodolan perusahaan NBIX (Neurocrine Biosciences)|Pendapatan lan volume dodolan regencellbioscience.com (RGC)|Pendapatan perusahaan Axsome Therapeutics, Inc. AXSM|ACAD: Volume dodolan perusahaan|Xenon Pharmaceuticals Inc - Pendapatan lan volume dodolan|Total pendapatan perusahaan Viking Therapeutics Corp|SUPN: Pendapatan lan volume dodolan|catalystpharma.com (CPRX) - Pendapatan lan volume dodolan|DNLI (Denali Therapeutics Inc.) - Pendapatan lan volume dodolan|Dodolan perusahaan Harmony Biosciences Inc (HRMY)|Pendapatan lan volume dodolan BHVN|Pendapatan reged perusahaan Amylyx Corp|Trevi Therapeutics - Dodolan perusahaan|Pendapatan lan volume dodolan praxismedicines.com PRAX|AVXL - Pendapatan perusahaan|CBLL (CeriBell Inc) - Volume dodolan perusahaan|PRTA: Pendapatan lan volume dodolan|Total pendapatan perusahaan Alector (ALEC)|Dodolan perusahaan ANNX|Pendapatan lan volume dodolan Omeros Corp.|Pendapatan perusahaan Neurogene (NGNE)|VYGR (Voyager Therapeutics Inc) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Neumora Therapeutics Inc NMRA|Scilex Holding Company, Inc. (SCLX) - Total pendapatan perusahaan|Tevogen Bio Holdings - Pendapatan lan volume dodolan|ACOG - Pendapatan lan volume dodolan|CGTX: Pendapatan lan volume dodolan|Dodolan perusahaan Inhibikase Therapeutics Inc|Dodolan perusahaan SAVA|ASRT: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan COYA|Pendapatan reged perusahaan vistagen.com|Pendapatan perusahaan Ovid Therapeutics OVID|ABOS - Dodolan perusahaan|CRVO - Pendapatan perusahaan|Alterity Therapeutics (ATHE) - Dodolan perusahaan|CLNN (clene.com) - Dodolan perusahaan|PepGen (PEPG) - Pendapatan lan volume dodolan|Pendapatan perusahaan Jupiter Neurosciences Inc|Volume dodolan perusahaan RLMD (Relmada Therapeutics Inc)|Pendapatan lan volume dodolan ANVS|GRCE - Total pendapatan perusahaan|Pendapatan lan volume dodolan AIFF (Firefly Neuroscience, Inc)|Pendapatan lan volume dodolan ANEW Medical KLTO|NeuroSense Therapeutics, Ltd. - Pendapatan lan volume dodolan|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Dodolan perusahaan|MTVA: Pendapatan lan volume dodolan|NRXS - Pendapatan reged perusahaan|Dodolan perusahaan HSDT|Pendapatan lan volume dodolan Passage Bio Corp|Pendapatan perusahaan Neuphoria Therapeutics Inc. (NEUP)|Minerva Neurosciences Inc - Volume dodolan perusahaan|Pendapatan lan volume dodolan ATHA (Athira)|Addex (ADXN) - Total pendapatan perusahaan|ALZN: Dodolan perusahaan|CYCN - Pendapatan lan volume dodolan|protagenic.com (PTIX) - Pendapatan perusahaan|Pasithea Therapeutics Corp. - Pendapatan dodolan perusahaan|Pendapatan perusahaan Cortigent Inc|Total pendapatan perusahaan Avenue Therapeutics Inc ATXI|Pendapatan lan volume dodolan BCLI|Pendapatan lan volume dodolan caratherapeutics.com (CARA)|Pendapatan lan volume dodolan CHRO (Chromocell Therapeutics Corp.)|ELYM - Dodolan perusahaan|ITCI: Dodolan perusahaan|Pendapatan dodolan perusahaan LBPH (Longboard)|MRNS: Pendapatan lan volume dodolan|NKGN - Pendapatan reged perusahaan|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|Dodolan perusahaan Sage Therapeutics Inc. (SAGE)|Pendapatan perusahaan Neurotrope (SNPX)|Dodolan perusahaan Trevena Inc TRVN|Vigil Neuroscience, Inc. - Dodolan perusahaan|Pendapatan lan volume dodolan Anew Medical Inc. WENA|CERE - Pendapatan perusahaan
